Current trends in screening and secondary prevention of colorectal cancer

M. Crespi, V. Stigliano, D. Assisi

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Colorectal cancer is one of the most frequent neoplasms in Western countries with an estimated 400,000 deaths per year worldwide. Several randomized studies have demonstrated that screening programs with FOBT (Fecal Occult Blood Test) reduce mortality from 18 to 33%, whereas case-control and cohort studies with endoscopy have shown a mortality reduction ranging from 60 to 76%. The target population for secondary prevention is men and women aged more than 50 years and younger subjects in case first-degree relatives are affected or the family pedigree raises the suspicion of a genetic syndrome. This report summarizes the results of different screening strategies for average risk patients (FOBT, anamnestic risk questionnaire, sigmoidoscopy, colonoscopy and virtual colonoscopy) and the surveillance protocols applicable to high-risk patients, particularly for hereditary syndromes such as HNPCC and FAP.

Original languageEnglish
Pages (from-to)1635-1640
Number of pages6
JournalHepato-Gastroenterology
Volume48
Issue number42
Publication statusPublished - 2001

Fingerprint

Secondary Prevention
Colorectal Neoplasms
Occult Blood
Hematologic Tests
Computed Tomographic Colonography
Sigmoidoscopy
Mortality
Health Services Needs and Demand
Colonoscopy
Pedigree
Endoscopy
Case-Control Studies
Cohort Studies
Neoplasms

Keywords

  • Colorectal cancer screening
  • Genetic syndromes

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Current trends in screening and secondary prevention of colorectal cancer. / Crespi, M.; Stigliano, V.; Assisi, D.

In: Hepato-Gastroenterology, Vol. 48, No. 42, 2001, p. 1635-1640.

Research output: Contribution to journalArticle

@article{232b13f5dbd2497e8289bebbe7359b25,
title = "Current trends in screening and secondary prevention of colorectal cancer",
abstract = "Colorectal cancer is one of the most frequent neoplasms in Western countries with an estimated 400,000 deaths per year worldwide. Several randomized studies have demonstrated that screening programs with FOBT (Fecal Occult Blood Test) reduce mortality from 18 to 33{\%}, whereas case-control and cohort studies with endoscopy have shown a mortality reduction ranging from 60 to 76{\%}. The target population for secondary prevention is men and women aged more than 50 years and younger subjects in case first-degree relatives are affected or the family pedigree raises the suspicion of a genetic syndrome. This report summarizes the results of different screening strategies for average risk patients (FOBT, anamnestic risk questionnaire, sigmoidoscopy, colonoscopy and virtual colonoscopy) and the surveillance protocols applicable to high-risk patients, particularly for hereditary syndromes such as HNPCC and FAP.",
keywords = "Colorectal cancer screening, Genetic syndromes",
author = "M. Crespi and V. Stigliano and D. Assisi",
year = "2001",
language = "English",
volume = "48",
pages = "1635--1640",
journal = "Acta hepato-splenologica",
issn = "0172-6390",
publisher = "H.G.E. Update Medical Publishing Ltd.",
number = "42",

}

TY - JOUR

T1 - Current trends in screening and secondary prevention of colorectal cancer

AU - Crespi, M.

AU - Stigliano, V.

AU - Assisi, D.

PY - 2001

Y1 - 2001

N2 - Colorectal cancer is one of the most frequent neoplasms in Western countries with an estimated 400,000 deaths per year worldwide. Several randomized studies have demonstrated that screening programs with FOBT (Fecal Occult Blood Test) reduce mortality from 18 to 33%, whereas case-control and cohort studies with endoscopy have shown a mortality reduction ranging from 60 to 76%. The target population for secondary prevention is men and women aged more than 50 years and younger subjects in case first-degree relatives are affected or the family pedigree raises the suspicion of a genetic syndrome. This report summarizes the results of different screening strategies for average risk patients (FOBT, anamnestic risk questionnaire, sigmoidoscopy, colonoscopy and virtual colonoscopy) and the surveillance protocols applicable to high-risk patients, particularly for hereditary syndromes such as HNPCC and FAP.

AB - Colorectal cancer is one of the most frequent neoplasms in Western countries with an estimated 400,000 deaths per year worldwide. Several randomized studies have demonstrated that screening programs with FOBT (Fecal Occult Blood Test) reduce mortality from 18 to 33%, whereas case-control and cohort studies with endoscopy have shown a mortality reduction ranging from 60 to 76%. The target population for secondary prevention is men and women aged more than 50 years and younger subjects in case first-degree relatives are affected or the family pedigree raises the suspicion of a genetic syndrome. This report summarizes the results of different screening strategies for average risk patients (FOBT, anamnestic risk questionnaire, sigmoidoscopy, colonoscopy and virtual colonoscopy) and the surveillance protocols applicable to high-risk patients, particularly for hereditary syndromes such as HNPCC and FAP.

KW - Colorectal cancer screening

KW - Genetic syndromes

UR - http://www.scopus.com/inward/record.url?scp=0035662198&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035662198&partnerID=8YFLogxK

M3 - Article

VL - 48

SP - 1635

EP - 1640

JO - Acta hepato-splenologica

JF - Acta hepato-splenologica

SN - 0172-6390

IS - 42

ER -